A new AHIP report makes baseless claims that hospitals drive up specialty drug costs when in fact insurance companies drive up profits by steering patients to their own specialty pharmacies, write AHA’s Mark Howell, director of policy and patient safety, and Bharath Krishnamurthy, director of health analytics and policy. “The report, which is fraught with half-truths and methodological flaws, is nothing more than a blatant attempt to deflect from the obvious — insurance companies continue to raise premiums for their enrollees and employer clients while pocketing billions in profits.” READ MORE

Related News Articles

Headline
The Food and Drug Administration will accept comments through Nov. 17 on draft guidance for labeling proposed biosimilar and interchangeable biosimilar…
Headline
A new Centers for Medicare & Medicaid Services fact sheet reviews how the agency selected the first 10 Part D drugs to include in the Medicare Drug Price…
Headline
Health and Human Services Secretary Xavier Becerra last week declared a public health emergency for Florida in response to Hurricane Idalia and waived or…
Headline
The Centers for Medicare & Medicaid Services recently awarded 57 organizations $98.6 million in navigator grants to help consumers enroll in health…
Headline
The Centers for Medicare & Medicaid Services sent to each state letters regarding compliance with federal requirements related to automatic eligibility…
Headline
A three-judge panel in federal court last week partially revived a class action lawsuit against UnitedHealth Group subsidiary United Behavioral Health,…